newsfilter
← Latest News
Business Wire·

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics

Repare Therapeutics Inc. ("Repare") (NASDAQ:RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its discovery platforms, including certain platform and program